Literature DB >> 9240365

Underreporting of cocaine use at posttreatment follow-up and the measurement of treatment effectiveness.

A Lundy1, E Gottheil, A T McLellan, S P Weinstein, R C Sterling, R D Serota.   

Abstract

Substance abusers, especially cocaine abusers, may underreport their substance use in outcome interviews. Follow-up interviews were conducted and urine specimens were obtained on 633 persons 9 months after admission to a 3-month cocaine treatment program. Although 422 (67%) reported no use of cocaine in the past 30 days, 134 of these (32%) had cocaine-positive urines. This group did not differ on most characteristics at intake or follow-up from the 288 with cocaine-negative urines. The amount of treatment received did affect willingness to admit drug use. Of 132 treatment completers who reported no cocaine use at follow-up, 21 (16%) had positive urines. Of 91 early dropouts who also reported no cocaine use, 36 (40%) had positive urines. This differential rate of underreporting had the effect of seriously underrepresenting the effectiveness of treatment completion as compared with little or no treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9240365     DOI: 10.1097/00005053-199707000-00007

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  4 in total

1.  It Takes a Village to Deliver and Test Child and Family-Focused Services.

Authors:  Mary M McKay; Geetha Gopalan; Lydia M Franco; Kosta Kalogerogiannis; Mari Umpierre; Orly Olshtain-Mann; William Bannon; Laura Elwyn; Leah Goldstein
Journal:  Res Soc Work Pract       Date:  2010

2.  Prize-based contingency management for the treatment of substance abusers: a meta-analysis.

Authors:  Lois A Benishek; Karen L Dugosh; Kim C Kirby; Jason Matejkowski; Nicolle T Clements; Brittany L Seymour; David S Festinger
Journal:  Addiction       Date:  2014-05-23       Impact factor: 6.526

3.  Reward-related dorsal striatal activity differences between former and current cocaine dependent individuals during an interactive competitive game.

Authors:  Christopher J Hyatt; Michal Assaf; Christine E Muska; Rivkah I Rosen; Andre D Thomas; Matthew R Johnson; Jennifer L Hylton; Melissa M Andrews; Brady A Reynolds; John H Krystal; Marc N Potenza; Godfrey D Pearlson
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

4.  Study protocol of the ESUB-MG cluster randomized trial: a pragmatic trial assessing the implementation of urine drug screening in general practice for buprenorphine maintained patients.

Authors: 
Journal:  BMC Fam Pract       Date:  2016-03-01       Impact factor: 2.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.